Therapy Areas: Devices
TechCare names new chief executive officer of Novomic
16 January 2019 - TechCare Corp (OTCQB: TECR), a technology company with a revolutionary delivery platform that uses vapour technology for natural health, wellness and beauty treatments, announced yes...
Quanticate launches QVigilance
16 January 2019 - Quanticate, a global data-focused clinical research organisation, has introduced QVigilance to offer dedicated pharmacovigilance (PV) and risk management services, it was reported ye...
Perrigo names new executive vice president and chief scientific officer
15 January 2019 - Ireland-based Perrigo Company plc (NYSE, TASE: PRGO) announced yesterday that it has named James Dillard as its new executive vice president and chief scientific officer.In this new ...
Abbott wins US FDA approval for the Amplatzer Piccolo Occluder to treat patent ductus arteriosus (PDA) in premature babies
15 January 2019 - Healthcare company Abbott (NYSE:ABT) revealed on Monday that it has passed US Food and Drug Administration (FDA) approval for the Amplatzer Piccolo Occluder for the treatment of one ...
Additive Orthopaedics passes US FDA clearance for Patient Specific 3D Printed Locking Lattice Plates
15 January 2019 - Additive Orthopaedics LLC reported on Monday the receipt of the US FDA 510(k) clearance for its Patient Specific 3D Printed Locking Lattice Plates indicated for alignment, stabilisat...
US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy
14 January 2019 - - The US Food and Drug Administration accepted for filing the company's New Drug Applications for tafamidis for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). ...
Related Headlines

Cantel Medical Corp closes acquisition of Vista Research Group LLC

AWAK Technologies passes US FDA breakthrough device designation for wearable peritoneal dialysis device

ulrich medical USA Inc reports availability of solidity vertebral body replacement device for complex spine applications

Endologix Names Zehren as Chief Commercial Cfficer

TELA Bio wins US FDA's marketing clearance for large size OviTex reinforced bioScaffolds for hernia repair

Amgen & UCB partnership wins marketing authorisation in Japan for EVENITY to treat osteoporosis

ArcherDX wins US FDA breakthrough device designation for both liquid biopsy and tissue companion diagnostic assay test

PCI Pharma Services to invest to expand biotech technologies

Empatica wins first of its kind US FDA clearance for Embrace for children diagnosed with epilepsy

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia

Veristat Touts Support for 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals

MicroVention Inc's WEB Aneurysm Embolization System wins US FDA PMA approval for the embolisation of wide neck bifurcation aneurysms

Impel updates positive results from Phase 1 trial of INP105 in treating acute agitation in bipolar I disorder and schizophrenia

US Merck's Keytruda Receives Five New Approvals in Japan, Including in Advanced Non-Small Cell Lung Cancer (NSCLC), as Adjuvant Therapy for Melanoma, and in Advanced Microsatellite Instability-High (MSI-H) Tumors

Bruin Biometrics LLC wins US FDA's de novo marketing authorisation for first-of-its-kind SEM Scanner for assessing the risk of pressure ulcers